Flexion Therapeutics to Report Second-Quarter 2020 Financial Results on August 5, 2020
July 30 2020 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it
will report its second-quarter 2020 financial results and recent
business highlights after the close of the U.S. financial markets
on Wednesday, August 5, 2020.
About Flexion Therapeutics Flexion
Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company
focused on the development and commercialization of novel, local
therapies for the treatment of patients with musculoskeletal
conditions, beginning with osteoarthritis, the most common form of
arthritis. The Company's core values are focus, ingenuity,
tenacity, transparency and fun. Visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsT: 781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Sep 2023 to Sep 2024